Repligen appoints Robert Spurr senior VP and CCO
This article was originally published in Scrip
Executive Summary
Robert Spurr has joined Repligen Corporation as senior vice-president of sales and marketing and chief commercial officer. Mr Spurr will be responsible for establishing the commercial organisation to sell SecreFlo (secretin) in the US (pending FDA approval) and overseeing the commercial operations of the company's bioprocessing business. He previously served as vice-president of sales and marketing for Ortho-McNeil, a division of Johnson and Johnson.